Aker BioMarine AS (Aker BioMarine), a subsidiary of Aker ASA, is a biotechnology company focused on advancing human health and nutrition. It is a leading supplier of science-based specialty ingredients for dietary supplements, functional nutrition, and emerging health solutions.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Aker BioMarine has undertaken several R&D initiatives focused on advancing scientific understanding of krill oil nutrients and their biological effects. In 2025, the company continued to deepen its understanding of krill’s biological properties and convert that insight into clinically relevant innovations. The company has been involved in approximately 200 scientific studies since 2006, reflecting its sustained engagement with the academic community. Aker BioMarine's research priorities increasingly reflect evolving consumer health trends, with a growing emphasis on healthy aging, brain health, muscle function, metabolic health, and exercise and sport. The company became a partner in the Boomerang project, a European research initiative aimed at supporting healthy cognitive aging through nutritional and lifestyle interventions. Additionally, a human clinical trial on Lysoveta was initiated in 2025 to support brain-related health claims. The R&D unit of Aker BioMarine is its innovation hub located in Houston, USA, which supports manufacturing and research capabilities. This unit is responsible for managing the company's R&D activities, including the development of krill-based health and nutrition products. Aker BioMarine holds 160 granted patents covering production processes and nutraceutical applications. The company has a global sales and distribution network, reaching customers in over 60 countries. The company has also formed major technology alliances, such as its partnership in the Boomerang project and collaborations with academic institutions.